Competitive collaboration in the pharmaceutical and biotechnology industry

Drug Discovery Today

Volumn 14, Issue 23-24, 2009, Pages 1079-1081

  Bingham, Alph ^a,b,c   Ekins, Sean ^d,e,f,g  

^a Cascade Consulting   (United States)

^b InnoCentive Inc   (United States)

^c Monitor Talent   (United States)

^d Collaborative Drug Discovery Inc ^*  (United States)

^e Collaborations in Chemistry ^*  (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMERCIAL PHENOMENA; COOPERATION; DRUG INDUSTRY; DRUG RESEARCH; ECONOMIC ASPECT; EDITORIAL; INFORMATION DISSEMINATION; PATENT; PRODUCT DEVELOPMENT;

BIOTECHNOLOGY; DRUG DISCOVERY; DRUG INDUSTRY; ECONOMIC COMPETITION; INTERINSTITUTIONAL RELATIONS; PLANNING TECHNIQUES;

EID: 71749108117     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.10.003     Document Type: Editorial

References (9)

1. Barnes M.R., et al. Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery. Nat. Rev. Drug Discov. 8 (2009) 701-708
2. Ekins, S. and Williams A.J. (2009) Precompetitive Preclinical ADME/Tox Data: Set It Free on The Web to Facilitate Computational Model Building and Assist Drug Development. Lab Chip, in press, doi:10.1039/b917760b
3. DiMasi J.A. Risks in new drug development: approval success rates for investigational drugs. Clin. Pharmacol. Ther. 69 (2001) 297-307
4. DiMasi J.A., et al. The price of innovation: new estimates of drug development costs. J. Health Econ. 22 (2003) 151-185
5. Hunter A.J. The Innovative Medicines Initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients. Drug Discov. Today 13 (2008) 371-373
6. Kamel N., et al. The Innovative Medicines Initiative (IMI): a new opportunity for scientific collab oration between academia and industry at the European level. Eur. Respir. J. 31 (2008) 924-926
7. Bangs A. Predictive biosimulation and virtual patients in pharmaceutical R and D. Stud. Health Technol. Informat. 111 (2005) 37-42
8. Hohman M., et al. Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery. Drug Disc. Today 14 (2009) 261-270
9. FDA (2004) Innovation stagnation: challenge and opportunity on the critical path to new medicinal products